Want to join the conversation?
$BCR's net sales of surgical specialty products in 2015 rose 3% (6% on constant currency basis) from last year. This rise is primarily due to growth in sales of biosurgery products and synthetic hernia repair products. U.S. sales of surgical specialty products rose by 7%, while International sales slid by 8% (up 2% on constant currency).
Apple ($AAPL) reported decline in sales and profits from comparable quarter last year, attributing the decline to announcement of iPhone 7/7s. Sales and profit are being guided higher for next quarter. Apple is a solid company and will continue to dominate tech and consumer electronics segment for a while. Personally, looks like there is little downside in this investment.
Waiting with fingers crossed for $AAPL’s fourth quarter earnings.
Looking ahead to $AAPL earnings release later in the afternoon today? Gene Munster, analyst from Piper Jaffrey and the most respected authority for Apple, had this to say - "The second and slightly larger group of investors believe the tail of the iPhone 7 is irrelevant, and is betting that the iPhone 10th Anniversary will yield a jump in growth from flat to up ~15%."